142 related articles for article (PubMed ID: 6236260)
1. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.
Brostoff SW; Mason DW
J Immunol; 1984 Oct; 133(4):1938-42. PubMed ID: 6236260
[TBL] [Abstract][Full Text] [Related]
2. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune effector cells. V.A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis.
Swanborg RH
J Immunol; 1983 Apr; 130(4):1503-5. PubMed ID: 6187808
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
[TBL] [Abstract][Full Text] [Related]
5. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis.
Burns J; Rosenzweig A; Zweiman B; Moskovitz A; Lisak R
J Immunol; 1984 Jun; 132(6):2690-2. PubMed ID: 6202757
[TBL] [Abstract][Full Text] [Related]
6. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody.
Waldor MK; Mitchell D; Kipps TJ; Herzenberg LA; Steinman L
J Immunol; 1987 Dec; 139(11):3660-4. PubMed ID: 3500226
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP
Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838
[TBL] [Abstract][Full Text] [Related]
8. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
[TBL] [Abstract][Full Text] [Related]
9. Effect of HgCl2 on experimental allergic encephalomyelitis in Lewis rats. HgCl2-induced down-modulation of the disease.
Pelletier L; Rossert J; Pasquier R; Villarroya H; Belair MF; Vial MC; Oriol R; Druet P
Eur J Immunol; 1988 Feb; 18(2):243-7. PubMed ID: 2450757
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.
Beyersdorf N; Gaupp S; Balbach K; Schmidt J; Toyka KV; Lin CH; Hanke T; Hünig T; Kerkau T; Gold R
J Exp Med; 2005 Aug; 202(3):445-55. PubMed ID: 16061730
[TBL] [Abstract][Full Text] [Related]
11. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
12. Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis.
Hickey WF; Gonatas NK; Kimura H; Wilson DB
J Immunol; 1983 Dec; 131(6):2805-9. PubMed ID: 6605991
[TBL] [Abstract][Full Text] [Related]
13. Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies.
Sriram S; Roberts CA
J Immunol; 1986 Jun; 136(12):4464-9. PubMed ID: 3086430
[TBL] [Abstract][Full Text] [Related]
14. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
Matsumoto Y; Fujiwara M
Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
[TBL] [Abstract][Full Text] [Related]
17. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
Korn T; Magnus T; Toyka K; Jung S
J Leukoc Biol; 2004 Nov; 76(5):950-60. PubMed ID: 15328336
[TBL] [Abstract][Full Text] [Related]
18. Lack of requirement for CD8+ cells in recovery from and resistance to experimental autoimmune encephalomyelitis.
Lohse AW; Schwerdt A; Herkel J; Spahn T; Meyer zum Büschenfelde KH
J Autoimmun; 1995 Jun; 8(3):395-404. PubMed ID: 7576000
[TBL] [Abstract][Full Text] [Related]
19. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H
J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217
[TBL] [Abstract][Full Text] [Related]
20. Modulation of experimental allergic encephalomyelitis in Lewis rats by monoclonal anti-T cell antibodies.
Brinkman CJ; Ter Laak HJ; Hommes OR
J Neuroimmunol; 1985 Jan; 7(4):231-8. PubMed ID: 3155525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
